Orange Book product · Brand (NDA)
DIULO
METOLAZONE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
METOLAZONE
Strength
2.5MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 018535
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 1987MYKROXBrand (NDA)
NDA 019532 · CHARTWELL MOLECULAR
- —ZAROXOLYNBrand (NDA)
NDA 017386 · I3 PHARMS
- 2024METOLAZONEGeneric (ANDA)
ANDA 217563 · MICRO LABS
- 2024METOLAZONEGeneric (ANDA)
ANDA 218606 · IXORA LIFESCIENCE
- 2022METOLAZONEGeneric (ANDA)
ANDA 216216 · NE RX PHARMA
- 2022METOLAZONEGeneric (ANDA)
ANDA 215616 · RENATA
- 2021METOLAZONEGeneric (ANDA)
ANDA 215184 · RUBICON RESEARCH
- 2021METOLAZONEGeneric (ANDA)
ANDA 213827 · INNOGENIX
- 2021METOLAZONEGeneric (ANDA)
ANDA 214799 · UNICHEM
- 2020METOLAZONEGeneric (ANDA)
ANDA 213251 · ALEMBIC
- 2004METOLAZONEGeneric (ANDA)
ANDA 076891 · WATSON LABS
- 2004METOLAZONEGeneric (ANDA)
ANDA 076482 · ROXANE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
